{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T20:04:06Z","timestamp":1760645046358},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1995,3,1]],"date-time":"1995-03-01T00:00:00Z","timestamp":794016000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[1995,3]]},"DOI":"10.1007\/bf01520289","type":"journal-article","created":{"date-parts":[[2005,4,18]],"date-time":"2005-04-18T23:15:50Z","timestamp":1113866150000},"page":"88-94","source":"Crossref","is-referenced-by-count":27,"title":["Increased tumor cell reactivity and complement-dependent cytotoxicity with mixtures of monoclonal antibodies against different gangliosides"],"prefix":"10.1007","volume":"40","author":[{"given":"Shengle","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Friedhelm","family":"Helling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth O.","family":"Lloyd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip O.","family":"Livingston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","first-page":"6840","volume":"49","author":"D Berd","year":"1989","unstructured":"Berd D, Herlyn M, Koprowski H, Mastrangelo MJ (1989) Flow cytometric determination of the frequency and heterogeneity of expression of human melanoma-associated antigens. Cancer Res 49:6840","journal-title":"Cancer Res"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0022-1759(86)90457-6","volume":"86","author":"K Blomberg","year":"1986","unstructured":"Blomberg K, Granberg C, Hemmila I, Lovgren T (1986) Europium-labelled target cells in an assay of natural killer cell activity. I. A novel non-radioactive method based on time-resolved fluorescence. J Immunol Methods 86:225","journal-title":"J Immunol Methods"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"7453","DOI":"10.1016\/S0021-9258(17)42812-2","volume":"259","author":"DA Cheresh","year":"1984","unstructured":"Cheresh DA, Varki AP, Varki NM, Stallcup WB, Levine JM, Reisfeld RA (1984) A monoclonal antibody recognizes anO-acetylated sialic acid in a human melanoma-associated ganglioside. J Biol Chem 259:7453","journal-title":"J Biol Chem"},{"key":"CR4","first-page":"2642","volume":"45","author":"N-K V Cheung","year":"1985","unstructured":"Cheung N-K V, Saarinen UM, Neely JE, Landmeier B, Donovan D, Coccia PF (1985) Monoclonal antibodies to a glycolipid antigen on human neuroblastoma cells. Cancer Res 45:2642","journal-title":"Cancer Res"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1200\/JCO.1987.5.9.1430","volume":"5","author":"N-K V Cheung","year":"1987","unstructured":"Cheung N-K V, Lazarus H, Miraldi FD, Abramowsaky CR, Kallic S, Saarinen UM, Spitzer T, Strandjord SE, Coccia PF, Berger NA (1987) Ganglioside GD2 specific monoclonal antibody 3F8: a phase-I study in patients with neuroblastoma and malignant melanoma. J Clin Oncol 5:1430","journal-title":"J Clin Oncol"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0022-1759(12)80023-8","volume":"147","author":"J Cui","year":"1992","unstructured":"Cui J, Bystryn J-C (1992) An improved europium release assay for complement-mediated cytolysis. J Immunol Methods 147:13","journal-title":"J Immunol Methods"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"6114","DOI":"10.1073\/pnas.77.10.6114","volume":"77","author":"WG Dippold","year":"1980","unstructured":"Dippold WG, Lloyd KO, Li LT, Ikeda H, Oettgen HF, Old LJ (1980) Cell-surface antigens of human malignant melanoma: definition of six antigenic systems with monoclonal antibodies. Proc Natl Acad Sci USA 77:6114","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/ijc.2910530407","volume":"53","author":"WB Hamilton","year":"1993","unstructured":"Hamilton WB, Helling F, Lloyd KO, Livingston PO (1993) Ganglioside expression on human malignant melanoma assessed by quantitative immune thin-layer chromatography. Int J Cancer 53:566","journal-title":"Int J Cancer"},{"key":"CR9","first-page":"491","volume":"34","author":"WB Hamilton","year":"1993","unstructured":"Hamilton WB, Helling F, Livingston PO (1993) Ganglioside expression on sarcoma and small-cell lung carcinoma compared to tumors of neuroectodermal origin (abstract). Proc Am Assoc Cancer Res 34:491","journal-title":"Proc Am Assoc Cancer Res"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1073\/pnas.82.4.1242","volume":"82","author":"AN Houghton","year":"1985","unstructured":"Houghton AN, Mintzer D, Cordon-Cardo C, Welt S, Fliegel B, Vadhan S, Carswell E, Melamed MR, Oettgen HF, Old LJ (1985) Mouse monoclonal IgG3 antibody detecting GD3 ganglioside: a phase-I trial in patients with malignant melanoma. Proc Natl Acad Sci USA 82:1242","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"8694","DOI":"10.1073\/pnas.83.22.8694","volume":"83","author":"RF Irie","year":"1986","unstructured":"Irie RF, Morton DL (1986) Regression of cutaneous metastatic melanoma by introlesional injection with human monoclonal antibody to ganglioside GD2. Proc Natl Acad Sci USA 83:8694","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/S0140-6736(89)92606-8","volume":"1","author":"RF Irie","year":"1989","unstructured":"Irie RF, Matsuki T, Morton DL (1989) Human monoclonal antibody to ganglioside GM2 for melamoma treatment. Lancet 1:786","journal-title":"Lancet"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1002\/ijc.2910520503","volume":"52","author":"S Kanda","year":"1992","unstructured":"Kanda S, Cochran AJ, Lee WR, Morton DL, Irie RF (1992) Variations in the ganglioside profile of uveal melanoma correlate with cytologic heterogeneity. Int J Cancer 52:682","journal-title":"Int J Cancer"},{"key":"CR14","first-page":"7045","volume":"49","author":"PO Livingston","year":"1989","unstructured":"Livingston PO, Ritter F, Srivastava P, Padavan M, Calves MJ, Oettgen HF, Old LJ (1989) Characterization of IgG and IgM antibodies induced in melanoma patients by immunization with purified GM2 ganglioside. Cancer Res 49:7045","journal-title":"Cancer Res"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1200\/JCO.1994.12.5.1036","volume":"12","author":"PO Livingston","year":"1994","unstructured":"Livingston PO, Wong GYC, Adluri S, Tao Y, Padavan M, Parente R, Hanlon C, Calves MJ, Helling F, Ritter G, Oettgen HF, Old LJ (1994) Improved survival in stage III melanoma patients with GM2 antibodies: a randomized trial of adjuvant vaccination with GM2 ganglioside. J Clin Oncol 12:1036","journal-title":"J Clin Oncol"},{"key":"CR16","first-page":"4948","volume":"52","author":"KO Lloyd","year":"1992","unstructured":"Lloyd KO, Gordon CM, Thampoe IJ, DiBenedetto C (1992) Cell surface accessibility of individual gangliosides in malignant melanoma cells to antibodies is influenced by the total ganglioside composition of the cells. Cancer Res 52:4948","journal-title":"Cancer Res"},{"key":"CR17","first-page":"4116","volume":"46","author":"EJ Natoli Jr","year":"1986","unstructured":"Natoli EJ Jr, Livingston PO, Pukel CS, Lloyd KO, Wiegandt H, Szalay J, Oettgen HF, Old LJ (1986) A murine monoclonal antibody detectingN-acetyl andN-glycoly GM2: characterization of cell surface reactivity. Cancer Res 46:4116","journal-title":"Cancer Res"},{"key":"CR18","first-page":"3891","volume":"49","author":"MH Ravindranath","year":"1989","unstructured":"Ravindranath MH, Morton DL, Irie RF (1989) An epitope common to gangliosidesO-acetyl-GD3 and GD3 recognized by antibodies in melanoma patients after active specific immunotherapy. Cancer Res 49:3891","journal-title":"Cancer Res"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/ijc.2910480312","volume":"48","author":"G Ritter","year":"1991","unstructured":"Ritter G, Boosfeld E, Adluri R, Calves M, Oettgen HF, Old LJ, Livingston PO (1991) Antibody response to immunization with ganglioside GD3 and GD3 congeners (lactones, amide and gangliosidol) in patients with malignant melanoma. Int J Cancer 48:379","journal-title":"Int J Cancer"},{"key":"CR20","first-page":"4342","volume":"52","author":"MN Saleh","year":"1992","unstructured":"Saleh MN, Khazaeli MB, Wheeler RH, Dropcho E, Liu T, Urist M, Miller DM, Lawson S, Dixon P, Russell CH, LoBuglio AF (1992) Phase I trial of the murine monoclonal anti-GD2 antibody 14G2a in metastatic melanoma. Cancer Res 52:4342","journal-title":"Cancer Res"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/j.1471-4159.1963.tb08933.x","volume":"10","author":"L Svennerholm","year":"1963","unstructured":"Svennerholm L (1963) Chromatographic separation of human brain gangliosides. J Neurochem 10:613","journal-title":"J Neurochem"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/ijc.2910350507","volume":"35","author":"T Tai","year":"1985","unstructured":"Tai T, Cahan LD, Tsuchida T, Saxton RE, Irie RF, Morton DL (1985) Immunogenicity of melanoma-associated gangliosides in cancer patients. Int J Cancer 35:607","journal-title":"Int J Cancer"},{"key":"CR23","first-page":"1278","volume":"47","author":"T Tsuchida","year":"1987","unstructured":"Tsuchida T, Ravindranath MH, Saxton RE, Irie RF (1987) Gangliosides of human melanoma: altered expression in vivo and vitro. Cancer Res 47:1278","journal-title":"Cancer Res"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/jnci\/78.1.45","volume":"78","author":"T Tsuchida","year":"1987","unstructured":"Tsuchida T, Saxton RE, Morton DL, Irie RF (1987) Gangliosides of human melanoma. J Nat Cancer Inst 78:45","journal-title":"J Nat Cancer Inst"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1002\/1097-0142(19890315)63:6<1166::AID-CNCR2820630621>3.0.CO;2-5","volume":"63","author":"T Tsuchida","year":"1989","unstructured":"Tsuchida T, Saxton RE, Morton DL, Irie RF (1989) Gangliosides of human melanoma. Cancer 63:1166","journal-title":"Cancer"}],"container-title":["Cancer Immunology Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01520289\/fulltext.html","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01520289.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01520289\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01520289","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,9]],"date-time":"2021-07-09T04:10:03Z","timestamp":1625803803000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01520289"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,3]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1995,3]]}},"alternative-id":["BF01520289"],"URL":"https:\/\/doi.org\/10.1007\/bf01520289","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,3]]}}}